Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors

Yoshikawa, Yuki; Imamura, Michio; Yamauchi, Masami; Hayes, C. Nelson; Aikata, Hiroshi; Okamoto, Wataru; Miyata, Yoshihiro; Okada, Morihito; Hattori, Noboru; Sugiyama, Kazuhiko; Yoshioka, Yukio; Toratani, Shigeaki; Takechi, Masaaki; Ichinohe, Tatsuo; Ueda, Tsutomu; Takeno, Sachio; Kobayashi, Tsuyoshi; Ohdan, Hideki; Teishima, Jun; Hide, Michihiro; Nagata, Yasushi; Kudo, Yoshiki; Iida, Koji; Chayama, Kazuaki

doi:10.1186/s12885-022-10327-7

BMC Cancer

Article metrics
Last updated: Fri, 26 Apr 2024 7:34:33 Z

Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors

Access & Citations

2172

Article Accesses
2

Web of Science
8

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com